These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 37000262)
1. YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma. Wang XW; Zhao R; Yang ZY; Li T; Yang JC; Wang XL; Li XT; Zhao XR; Li XZ; Wang XX J Cancer Res Clin Oncol; 2023 Aug; 149(10):7703-7716. PubMed ID: 37000262 [TBL] [Abstract][Full Text] [Related]
2. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma. Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417 [TBL] [Abstract][Full Text] [Related]
3. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells. Li X; Zhao X; Su X; Wen J; Yang S; Qin Y; Yan S; Yao Y; Li X; Wang X Arch Biochem Biophys; 2024 Aug; 758():110064. PubMed ID: 38897534 [TBL] [Abstract][Full Text] [Related]
4. JUND facilitates proliferation and angiogenesis of esophageal squamous cell carcinoma cell via MAPRE2 up-regulation. Zhang D; Pan G; Cheng N; Sun L; Zhou X; Li C; Zhao J Tissue Cell; 2023 Apr; 81():102010. PubMed ID: 36608637 [TBL] [Abstract][Full Text] [Related]
5. Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells. Wang XW; Yang ZY; Li T; Zhao XR; Li XZ; Wang XX Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37751128 [TBL] [Abstract][Full Text] [Related]
6. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147. Yin Z; Cai H; Wang Z; Jiang Y Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553 [TBL] [Abstract][Full Text] [Related]
7. Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma. Yu H; Jiang X; Jiang L; Zhou H; Bao J; Zhu X; Liu F; Huang J Med Sci Monit; 2020 Apr; 26():e920665. PubMed ID: 32330123 [TBL] [Abstract][Full Text] [Related]
8. Extracellular shuttling miR-21 contributes to esophageal cancers and human umbilical vein endothelial cell communication in the tumor microenvironment and promotes tumor angiogenesis by targeting phosphatase and tensinhomolog. Zheng S; Liao J; Sun M; Liu R; Lv J Thorac Cancer; 2023 Nov; 14(31):3119-3132. PubMed ID: 37726969 [TBL] [Abstract][Full Text] [Related]
9. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma. Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522 [TBL] [Abstract][Full Text] [Related]
10. miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway. Wei D; Ma Z; Zhu T; Wang H; Wang B; Fu L; Yu G Acta Cir Bras; 2023; 38():e385223. PubMed ID: 38055382 [TBL] [Abstract][Full Text] [Related]
11. Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression. Pan W; Wang Q; Zhang Y; Zhang N; Qin J; Li W; Wang J; Wu F; Cao L; Xu G Cell Physiol Biochem; 2016; 39(2):481-90. PubMed ID: 27383277 [TBL] [Abstract][Full Text] [Related]
12. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD. Yang F; Sun Z; Wang D; Du T BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779 [TBL] [Abstract][Full Text] [Related]
13. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239 [TBL] [Abstract][Full Text] [Related]
14. Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development. Sato S; Yamamoto H; Mukaisho K; Saito S; Hattori T; Yamamoto G; Sugihara H PLoS One; 2014; 9(2):e88831. PubMed ID: 24551170 [TBL] [Abstract][Full Text] [Related]
15. Sox2 induces tumorigenesis and angiogenesis of early-stage esophageal squamous cell carcinoma through secretion of Suprabasin. Takahashi K; Asano N; Imatani A; Kondo Y; Saito M; Takeuchi A; Jin X; Saito M; Hatta W; Asanuma K; Uno K; Koike T; Masamune A Carcinogenesis; 2020 Nov; 41(11):1543-1552. PubMed ID: 32055838 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. Yan J; Shi L; Lin S; Li Y Bioengineered; 2021 Dec; 12(1):5334-5347. PubMed ID: 34415232 [TBL] [Abstract][Full Text] [Related]
17. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Xu YB; Du QH; Zhang MY; Yun P; He CY Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2486-94. PubMed ID: 24089228 [TBL] [Abstract][Full Text] [Related]
18. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma. Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869 [TBL] [Abstract][Full Text] [Related]
20. Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma. Miao Y; Wang X; Lai Y; Huang Y; Yin H; Meng X; Liu H; Hou R; Lin W; Zhang X; Zhang X; Chai BC; Zhang F; Guo L; Yang S Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37264968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]